U.S. Markets open in 4 hrs 31 mins
  • S&P Futures

    3,251.25
    -51.00 (-1.54%)
     
  • Dow Futures

    26,149.00
    -408.00 (-1.54%)
     
  • Nasdaq Futures

    11,116.00
    -226.75 (-2.00%)
     
  • Russell 2000 Futures

    1,539.10
    -19.30 (-1.24%)
     
  • Crude Oil

    36.39
    +0.22 (+0.61%)
     
  • Gold

    1,871.30
    +3.30 (+0.18%)
     
  • Silver

    23.38
    +0.02 (+0.09%)
     
  • EUR/USD

    1.1673
    -0.0005 (-0.0467%)
     
  • 10-Yr Bond

    0.8350
    0.0000 (0.00%)
     
  • Vix

    39.32
    -0.96 (-2.38%)
     
  • GBP/USD

    1.2929
    +0.0006 (+0.0453%)
     
  • USD/JPY

    104.3830
    -0.2270 (-0.2170%)
     
  • BTC-USD

    13,262.36
    -111.83 (-0.84%)
     
  • CMC Crypto 200

    259.25
    +16.57 (+6.83%)
     
  • FTSE 100

    5,570.01
    -11.74 (-0.21%)
     
  • Nikkei 225

    22,977.13
    -354.81 (-1.52%)
     

AMAG HOLDINGS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of AMAG and Encourages Investors to Contact the Firm

Bragar Eagel & Squire
·2 mins read

NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) breached their fiduciary duties or violated the federal securities laws in connection with the company’s merger with Covis Group S.á. r.l.

Click here to learn more and participate in the action.

On October 1, 2020, AMAG announced that it had signed an agreement to be acquired by Covis Group for $498 million. Pursuant to the merger agreement, AMAG stockholders will receive $13.75 in cash for each share of AMAG common stock owned. The deal is scheduled to close in the fourth quarter of 2020.

Bragar Eagel & Squire is concerned that AMAG’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for AMAG’s stockholders.

If you own shares of AMAG and are concerned about the proposed merger, or you are interested in learning more about the investigation or your legal rights and remedies, please contact Melissa Fortunato or Alexandra Raymond by email at investigations@bespc.com or telephone at (646) 860-9157, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:
Bragar Eagel & Squire, P.C.
Melissa Fortunato, Esq.
Alexandra Raymond, Esq.
investigations@bespc.com
www.bespc.com